Drug
Zenapax
Zenapax: highest development phase Phase 2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zenapax NCT00198146 | Phase 2 | Newly Diagnosed With Type 1 Diabetes |
Latest
No recent events.
Follow Zenapax on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.